Systemic light-chain amyloidosis presenting with rapid progressive heart failure

Area of Science:

• Cardiology
• Hematology
• Pathology

Background:

• Systemic amyloid light-chain (AL) amyloidosis results from immunoglobulin light-chain protein deposition.
• It is a rapidly progressive condition affecting multiple organs, with cardiac involvement in 50% of cases.
• Median survival following diagnosis is poor, often around 5 months.

Observation:

• Transthoracic echocardiography may reveal characteristic findings in cardiac AL amyloidosis.
• Despite advancements, definitive diagnosis often requires tissue biopsy to confirm amyloid presence.
• The case presented highlights rapid, progressive heart failure as a presenting symptom.

Findings:

• Cardiac involvement is a frequent and serious complication of AL amyloidosis.
• Diagnostic modalities, while improving, still present challenges for timely identification.
• Prognosis remains poor for patients with significant cardiac involvement.

Implications:

• Improved diagnostic strategies are needed for earlier detection of cardiac AL amyloidosis.
• Further research into targeted therapies may improve outcomes for patients with this condition.
• Understanding the rapid progression is key to developing effective management plans.